Author

Sophie Draxler-Dworzak

Observed names: Sophie Draxler‐Dworzak, Sophie Dworzak

Institution: Medical University of Vienna

Observed institution: Medical University of Vienna

ORCID: 0009-0002-6375-593X

Observed ORCID: 0009-0002-6375-593X

OpenAlex ID: A5116492024

Evinacumab and reduced lipoprotein apheresis in pediatric homozygous familial hypercholesterolemia: a retrospective study on LDL-C

2025 · Charlotte Nigmann, Manuela Neyer, et al. · Atherosclerosis · 9

Lipid Dysregulation in Tangier Disease: A Case Series and Metabolic Characterization

2025 · Georg Semmler, Clemens Baumgartner, et al. · The Journal of Clinical Endocrinology & Metabolism · 5

Clinical Benefits Associated With Evinacumab in Pediatric Patients With Homozygous Familial Hypercholesterolemia

2026 · M. D. Reijman, Charlotte Nigmann, et al. · Journal of the American Heart Association

Impact of Liraglutide therapy on mitigating cardiovascular and metabolic comorbidities in adolescents with morbid obesity

2024 · Sophie Dworzak, Manuela Neyer, et al. · Atherosclerosis

Evinacumab use in pediatric patients with homozygous familial hypercholesterolemia (HOFH) undergoing lipoprotein apheresis: A monocentric evaluation of the impact on lipoprotein apheresis frequency

2024 · Charlotte De Gier, Manuela Neyer, et al. · Atherosclerosis

Works count: 5

Citation count: 14

H-index: 2

I10-index: